Robotic arm vs. stereotactic frame in deep brain stimulation surgery for movement disorders: a retrospective cohort study - Scorecard - MDSpire

Robotic arm vs. stereotactic frame in deep brain stimulation surgery for movement disorders: a retrospective cohort study

  • By

  • Doriam Perera

  • Pedro Roldán Ramos

  • Francesc Valldeoriola

  • Almudena Sánchez-Gómez

  • Abel Ferrés

  • Carlos Pérez-Baldioceda

  • Gloria Cabrera

  • Alejandra Mosteiro

  • Lorena Gómez

  • Marta Codes

  • Roberto Manfrellotti

  • Jordi Rumià

  • August 12, 2025

  • 0 min

Share

Clinical Scorecard: Comparison of Robotic Arm and Stereotactic Frame Techniques in Deep Brain Stimulation Surgery for Movement Disorders: A Retrospective Analysis

At a Glance

CategoryDetail
ConditionMovement disorders including Parkinson’s disease, essential tremor, and dystonia
Key MechanismsDeep brain stimulation (DBS) electrode implantation using stereotactic frame or robotic arm techniques
Target PopulationPatients undergoing DBS surgery for Parkinson’s disease and dystonia
Care SettingNeurosurgery Department in a hospital setting

Key Highlights

  • DBS is the surgical treatment of choice to improve quality of life in movement disorders.
  • Stereotactic frames have been the standard for precise and safe DBS electrode implantation.
  • Robotic stereotactic systems like Neuromate offer enhanced precision and are increasingly adopted.

Guideline-Based Recommendations

Diagnosis

  • Use clinical evaluation and imaging for diagnosis of Parkinson’s disease and dystonia prior to DBS surgery.

Management

  • Implant DBS electrodes using either stereotactic frame or robotic arm techniques with direct targeting under general anesthesia.
  • Employ intraoperative imaging (e.g., O-arm) for verification of electrode placement, especially when using novel robotic techniques.

Monitoring & Follow-up

  • Assess radiological accuracy postoperatively using radial and vector (Euclidean) errors via CT and MRI with automatic segmentation software.
  • Monitor clinical efficacy using Unified Parkinson’s Disease Rating Scale (UPDRS-III) and levodopa equivalent dose changes.
  • Follow patients for at least 3 months post-surgery to evaluate safety and initial clinical outcomes.

Risks

  • Consider potential for surgical complications including electrode placement deviation (radial deviation ≥ 2 mm) and pneumocephalus.
  • Be aware that robotic-assisted surgeries may have longer surgical times compared to frame-based techniques.

Patient & Prescribing Data

Patients with Parkinson’s disease and dystonia undergoing DBS surgery

Both stereotactic frame and robotic arm techniques provide precise electrode placement; robotic surgery may require additional intraoperative imaging initially but offers comparable safety and efficacy.

Clinical Best Practices

  • Maintain consistent surgical technique and neurosurgeon involvement regardless of implantation method to ensure comparability.
  • Use intraoperative imaging verification when adopting new robotic implantation techniques to ensure accuracy and safety.
  • Collect and analyze postoperative imaging with validated software tools to quantify electrode placement accuracy.
  • Monitor clinical scales and medication adjustments to assess treatment efficacy post-DBS.
  • Ensure ethical compliance and patient confidentiality in retrospective analyses.

References

Original Source(s)

Related Content